[HTML][HTML] Current landscape of preoperative neoadjuvant therapies for initial resectable colorectal cancer liver metastasis
XF Cheng, F Zhao, D Chen, FL Liu - World Journal of …, 2024 - ncbi.nlm.nih.gov
Colorectal cancer liver metastasis (CRLM) presents a clinical challenge, and optimizing
treatment strategies is crucial for improving patient outcomes. Surgical resection, a key …
treatment strategies is crucial for improving patient outcomes. Surgical resection, a key …
[HTML][HTML] Response to preoperative chemotherapy: impact of change in total burden score and mutational tumor status on prognosis of patients undergoing resection …
Background Progression of colorectal liver metastasis (CRLM) on preoperative
chemotherapy has been associated with a worse prognosis compared with patients who …
chemotherapy has been associated with a worse prognosis compared with patients who …
External validation of two established clinical risk scores predicting outcome after local treatment of colorectal liver metastases in a nationwide cohort
K Bolhuis, GE Wensink, MAG Elferink, MJG Bond… - Cancers, 2022 - mdpi.com
Simple Summary Patients with colorectal liver metastases (CRLM) are able to achieve long-
term survival when they receive local treatment of CRLM (resection or tumor ablation) …
term survival when they receive local treatment of CRLM (resection or tumor ablation) …
KRAS mutations are influential in driving hepatic metastases and predicting outcome in colorectal cancer
Metastatic colorectal cancer (CRC) is a topic of intense research. KRAS mutations have
emerged as aggressive drivers of disease. Here we discuss the role of KRAS mutations in …
emerged as aggressive drivers of disease. Here we discuss the role of KRAS mutations in …
Reevaluating the prognostic value of ras mutation status in patients with resected liver metastases from colorectal cancer: A systematic review and meta‐analysis
E Pikoulis, D Papaconstantinou… - Journal of Hepato …, 2021 - Wiley Online Library
Background Although the value of Rat Sarcoma Oncogene (RAS) mutation status in
predicting long‐term outcomes in patients with colorectal liver metastases (CRLM) is widely …
predicting long‐term outcomes in patients with colorectal liver metastases (CRLM) is widely …
[HTML][HTML] Prediction of survival in patients with colorectal liver metastases-development and validation of a prognostic score model
C Villard, A Abdelrafee, M Habib, N Ndegwa… - European Journal of …, 2022 - Elsevier
Background Metastatic spread of colorectal cancer to the liver impacts prognosis. Advances
in chemotherapy have resulted in increased resectability rates and thereby improved …
in chemotherapy have resulted in increased resectability rates and thereby improved …
[HTML][HTML] Nomograms incorporating preoperative RDW level for the prediction of postoperative complications and survival in colorectal liver metastases after resection
Q Chen, R Mao, J Zhao, X Bi, Z Li… - Annals of Palliative …, 2021 - apm.amegroups.org
Background: This study aimed to investigate the predictive significance of preoperative red
cell volume distribution width (RDW) level for prognosis and to establish nomograms …
cell volume distribution width (RDW) level for prognosis and to establish nomograms …
Machine learning-based radiomics analysis in predicting RAS mutational status using magnetic resonance imaging
Purpose To assess the efficacy of radiomics features, obtained by magnetic resonance
imaging (MRI) with hepatospecific contrast agent, in pre-surgical setting, to predict RAS …
imaging (MRI) with hepatospecific contrast agent, in pre-surgical setting, to predict RAS …
[HTML][HTML] Molecular profiling and patient selection for the multimodal approaches for patients with resectable colorectal liver metastases
RLC Araujo, LG Fonseca, RO Silva… - … Surgery and Nutrition, 2024 - ncbi.nlm.nih.gov
Colorectal cancer represents the third most common cancer and about 20% are diagnosed
with synchronous metastatic disease. From a historical point of view, surgery remains the …
with synchronous metastatic disease. From a historical point of view, surgery remains the …
[HTML][HTML] Colorectal cancer liver metastases: an update of treatment strategy and future perspectives
D Hu, Y Pan, G Chen - Surgery in Practice and Science, 2021 - Elsevier
Introduction More than half of the colorectal cancer patients develop liver metastases in the
disease course, affecting at least 900,000 people worldwide each year. Regarding this …
disease course, affecting at least 900,000 people worldwide each year. Regarding this …